Kissei Pharmaceutical Co Ltd

TSE:4547 (Japan)   Ordinary Shares
円 3205.00 (+1.75%) May 24
13.00
P/B:
0.64
Market Cap:
円 141.68B ($ 902.67M)
Enterprise V:
円 97.09B ($ 618.55M)
Volume:
138.00K
Avg Vol (2M):
84.59K
Also Trade In:
Volume:
138.00K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Kissei Pharmaceutical Co Ltd ( TSE:4547 ) from 1990 to May 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Kissei Pharmaceutical stock (TSE:4547) PE ratio as of May 26 2024 is 13. More Details

Kissei Pharmaceutical Co Ltd (TSE:4547) PE Ratio (TTM) Chart

To

Kissei Pharmaceutical Co Ltd (TSE:4547) PE Ratio (TTM) Historical Data

Total 1230
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Kissei Pharmaceutical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-26 13.0 2024-03-19 13.3
2024-05-24 13.0 2024-03-18 13.6
2024-05-23 12.8 2024-03-15 13.6
2024-05-22 12.4 2024-03-14 13.7
2024-05-21 12.7 2024-03-13 13.8
2024-05-20 12.8 2024-03-12 13.9
2024-05-17 12.8 2024-03-11 13.7
2024-05-16 12.7 2024-03-08 13.7
2024-05-15 12.7 2024-03-07 13.2
2024-05-14 12.8 2024-03-06 13.1
2024-05-13 12.7 2024-03-05 12.8
2024-05-10 12.9 2024-03-04 12.9
2024-05-09 13.1 2024-03-01 12.8
2024-05-08 13.1 2024-02-29 12.7
2024-05-07 14.8 2024-02-28 12.7
2024-05-02 14.8 2024-02-27 12.7
2024-05-01 14.6 2024-02-26 12.6
2024-04-30 14.7 2024-02-22 12.3
2024-04-26 14.5 2024-02-21 12.3
2024-04-25 14.3 2024-02-20 12.4
2024-04-24 14.5 2024-02-19 12.4
2024-04-23 14.5 2024-02-16 12.3
2024-04-22 14.3 2024-02-15 12.1
2024-04-19 13.9 2024-02-14 12.2
2024-04-18 14.1 2024-02-13 12.1
2024-04-17 14.3 2024-02-12 11.8
2024-04-16 14.7 2024-02-09 11.8
2024-04-15 14.8 2024-02-08 11.9
2024-04-12 14.7 2024-02-07 11.8
2024-04-11 14.5 2024-02-06 11.6
2024-04-10 14.3 2024-02-05 11.7
2024-04-09 14.1 2024-02-02 11.8
2024-04-08 14.0 2024-02-01 11.8
2024-04-05 13.8 2024-01-31 11.9
2024-04-04 13.5 2024-01-30 11.8
2024-04-03 13.8 2024-01-29 11.7
2024-04-02 13.6 2024-01-26 11.7
2024-04-01 14.1 2024-01-25 12.0
2024-03-29 14.2 2024-01-24 11.9
2024-03-28 14.3 2024-01-23 12.1
2024-03-27 13.3 2024-01-22 11.9
2024-03-26 13.2 2024-01-19 11.8
2024-03-25 13.2 2024-01-18 12.0
2024-03-22 13.4 2024-01-17 12.0
2024-03-21 13.2 2024-01-16 12.1

Kissei Pharmaceutical Co Ltd (TSE:4547) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Kissei Pharmaceutical Co Ltd
NAICS : 325412
ISIN : JP3240600001

Share Class Description:

TSE:4547: Ordinary Shares
Description
Kissei Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. Pharmaceuticals is the company's reportable segment. The company's operations span across the globe, while the vast majority of revenue is generated in Japan, followed by Europe. Kissei operates a variety of subsidiaries. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.